{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:48:14Z","timestamp":1788526094595,"version":"build-2803163510"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["573547\/2008-4, 465293\/2014-0, 407164\/2015-4"],"award-info":[{"award-number":["573547\/2008-4, 465293\/2014-0, 407164\/2015-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["23038.009421\/2012-16"],"award-info":[{"award-number":["23038.009421\/2012-16"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["red001214"],"award-info":[{"award-number":["red001214"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00465","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T14:11:58Z","timestamp":1521123118000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent Trypanosoma cruzi CL-14 Strain Are Highly Antigenic and Protective against Leishmania infantum Challenge"],"prefix":"10.3389","volume":"9","author":[{"given":"Ana Paula M. M.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo F. M.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Doro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico C.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Damasceno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Tostes","family":"Gazzinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Junqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3389\/fimmu.2014.00480","article-title":"Deception and manipulation: the arms of Leishmania, a successful parasite","volume":"5","author":"Cec\u00edlio","year":"2014","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.179.4.1367","article-title":"CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major","volume":"179","author":"Wang","year":"1994","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fimmu.2016.00187","article-title":"Modulation of innate immune mechanisms to enhance Leishmania vaccine-induced immunity: role of coinhibitory molecules","volume":"7","author":"Gannavaram","year":"2016","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0005562","DOI":"10.1371\/journal.pntd.0005562","article-title":"Epitope mapping of recombinant Leishmania donovani virulence factor A2 (recLdVFA2) and canine leishmaniasis diagnosis using a derived synthetic bi-epitope","volume":"11","author":"Mendes","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1073\/pnas.94.16.8807","article-title":"Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"35508","DOI":"10.1074\/jbc.M305030200","article-title":"Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6940","DOI":"10.1128\/IAI.02032-05","article-title":"Leishmania chagasi T-cell antigens identified through a double library screen","volume":"74","author":"Martins","year":"2006","journal-title":"Infect Immun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.200","article-title":"Immune responses induced by the Leishmania donovani (Leishmania) A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania amazonensis (Leishmania) infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect Immun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.vaccine.2009.09.114","article-title":"Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis","volume":"28","author":"Mizbani","year":"2009","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1016\/j.vaccine.2008.05.091","article-title":"Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-\u03b3 and cytolytic activity by CD8+ T cells","volume":"26","author":"Resende","year":"2008","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania chagasi (Leishmania) in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.vaccine.2016.03.019","article-title":"Field randomized trial to evaluate the efficacy of the Leish-Tec\u00ae vaccine against canine visceral leishmaniasis in an endemic area of Brazil","volume":"34","author":"Regina-Silva","year":"2016","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0185438","DOI":"10.1371\/journal.pone.0185438","article-title":"Field trial of efficacy of the Leish-tec\u00ae vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates","volume":"12","author":"Grimaldi","year":"2017","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fimmu.2014.00213","article-title":"Genetically modified organisms and visceral leishmaniasis","volume":"5","author":"Chhajer","year":"2014","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/14760584.2017.1333426","article-title":"The use of transgenic parasites in malaria vaccine research","volume":"16","author":"Othman","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s004360050674","article-title":"Trypanosoma cruzi: lack of T cell abnormalities in mice vaccinated with live trypomastigotes","volume":"85","author":"Paiva","year":"1999","journal-title":"Parasitol Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19695","DOI":"10.1073\/pnas.1110030108","article-title":"Trypanosoma cruzi as an effective cancer antigen delivery vector","volume":"108","author":"Junqueira","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF00934390","article-title":"Trypanosoma cruzi: properties of a clone isolated from CL strain","volume":"77","author":"Lima","year":"1991","journal-title":"Parasitol Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.1112631","article-title":"The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease","volume":"309","author":"El-Sayed","year":"2005","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1017\/S0031182014000894","article-title":"Genome evolution in trypanosomatid parasites","volume":"142","author":"JACKSON","year":"2015","journal-title":"Parasitology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1128\/MCB.14.5.2975","article-title":"Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene","volume":"14","author":"Charest","year":"1994","journal-title":"Mol Cell Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00436-003-1004-5","article-title":"Expression of exogenous genes in Trypanosoma cruzi: improving vectors and electroporation protocols","volume":"92","author":"DaRocha","year":"2004","journal-title":"Parasitol Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e36245","DOI":"10.1371\/journal.pone.0036245","article-title":"Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine","volume":"7","author":"Junqueira","year":"2012","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1128\/JCM.40.5.1666","article-title":"Real-time PCR for detection and quantitation of Leishmania in mouse tissues","volume":"40","author":"Nicolas","year":"2002","journal-title":"J Clin Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.vetpar.2014.04.025","article-title":"Antibody responses induced by Leish-Tec\u00ae, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population","volume":"204","author":"de Souza Testasicca","year":"2014","journal-title":"Vet Parasitol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fimmu.2014.00134","article-title":"Live vaccination tactics: possible approaches for controlling visceral leishmaniasis","volume":"5","author":"Saljoughian","year":"2014","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.26719\/1997.3.2.284","article-title":"The experience of leishmanization in the Islamic Republic of Iran","volume":"3","author":"Nadim","year":"1997","journal-title":"East Mediterr Heal J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","article-title":"Case study for a vaccine against leishmaniasis","volume":"31","author":"Alvar","year":"2013","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.0105-2896.2006.00402.x","article-title":"Protective \u201cimmunity\u201d by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called \u201cimmunological memory\u201d","volume":"211","author":"Zinkernagel","year":"2006","journal-title":"Immunol Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0132794","DOI":"10.1371\/journal.pone.0132794","article-title":"Evaluation of live recombinant nonpathogenic Leishmania tarentolae expressing cysteine proteinase and A2 genes as a candidate vaccine against experimental canine visceral leishmaniasis","volume":"10","author":"Shahbazi","year":"2015","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fimmu.2014.00241","article-title":"Biomarkers of safety and immune protection for genetically modified live attenuated Leishmania vaccines against visceral leishmaniasis \u2013 discovery and implications","volume":"5","author":"Gannavaram","year":"2014","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13324","DOI":"10.1038\/ncomms13324","article-title":"Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation","volume":"7","author":"den Brok","year":"2016","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.tibtech.2004.04.006","article-title":"Codon bias and heterologous protein expression","volume":"22","author":"Gustafsson","year":"2004","journal-title":"Trends Biotechnol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"S467","DOI":"10.1098\/rsif.2008.0520.focus","article-title":"You\u2019re one in a googol: optimizing genes for protein expression","volume":"6","author":"Welch","year":"2009","journal-title":"J R Soc Interface"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e2853","DOI":"10.1371\/journal.pntd.0002853","article-title":"Clinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigen","volume":"8","author":"Grimaldi","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.intimp.2012.02.002","article-title":"Miltefosine triggers a strong proinflmmatory cytokine response during visceral leishmaniasis: role of TLR4 and TLR9","volume":"12","author":"Mukherjee","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s13071-016-1752-6","article-title":"Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec\u00ae and Leishmune\u00ae vaccines against visceral leishmaniasis","volume":"9","author":"de Mendon\u00e7a","year":"2016","journal-title":"Parasit Vectors"},{"key":"B47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.4049\/jimmunol.181.2.1333","article-title":"Recruitment and endo-lysosomal activation of TLR9 in dendritic cells infected with Trypanosoma cruzi","volume":"181","author":"Bartholomeu","year":"2008","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s13071-016-1598-y","article-title":"Leishmania infantum-specific production of IFN-\u03b3 and IL-10 in stimulated blood from dogs with clinical leishmaniosis","volume":"9","author":"Solano-Gallego","year":"2016","journal-title":"Parasit Vectors"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0004468","DOI":"10.1371\/journal.pntd.0004468","article-title":"Successful treatment of human visceral leishmaniasis restores antigen-specific IFN-\u03b3, but not IL-10 production","volume":"10","author":"Adem","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e106304","DOI":"10.1371\/journal.pone.0106304","article-title":"Genome-wide screening and identification of new Trypanosoma cruzi antigens with potential application of chronic Chagas disease diagnosis","volume":"9","author":"Reis-Cunha","year":"2014","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.4049\/jimmunol.179.10.6889","article-title":"Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic Trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming","volume":"179","author":"Hoft","year":"2007","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.vaccine.2015.01.044","article-title":"Efficacy of a trans-sialidase-ISCOMATRIX subunit candidate to protect against experimental Chagas disease","volume":"33","author":"Bontempi","year":"2015","journal-title":"Vaccine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e22011","DOI":"10.1371\/journal.pone.0022011","article-title":"Subdominant\/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite","volume":"6","author":"Dominguez","year":"2011","journal-title":"PLoS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1089\/hum.2006.17.898","article-title":"Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase","volume":"17","author":"Machado","year":"2006","journal-title":"Hum Gene Ther"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1017\/S1462399410001560","article-title":"The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease","volume":"12","author":"Junqueira","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e0137683","DOI":"10.1371\/journal.pone.0137683","article-title":"Antigenicity, immunogenicity and protective efficacy of three proteins expressed in the promastigote and amastigote stages of Leishmania infantum against visceral leishmaniasis","volume":"10","author":"Martins","year":"2015","journal-title":"PLoS One"},{"key":"B58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","article-title":"Advances in aluminum hydroxide-based adjuvant research and its mechanism","volume":"11","author":"He","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fimmu.2012.00406","article-title":"Mechanism of immunopotentiation and safety of aluminum adjuvants","volume":"3","author":"Hogenesch","year":"2012","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.vaccine.2015.01.074","article-title":"Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in mice","volume":"33","author":"Zuest","year":"2015","journal-title":"Vaccine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.pt.2014.05.001","article-title":"Determinants of disease phenotype in trypanosomatid parasites","volume":"30","author":"McCall","year":"2014","journal-title":"Trends Parasitol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6372","DOI":"10.1128\/IAI.73.10.6372-6382.2005","article-title":"Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis","volume":"73","author":"Breton","year":"2005","journal-title":"Infect Immun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e2174","DOI":"10.1371\/journal.pntd.0002174","article-title":"Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis","volume":"7","author":"Saljoughian","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.molimm.2015.08.001","article-title":"Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB\/c mice model","volume":"67","author":"Katebi","year":"2015","journal-title":"Mol Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF00932410","article-title":"Negative tissue parasitism in mice injected with a noninfective clone ofTrypanosoma cruzi","volume":"81","author":"Lima","year":"1995","journal-title":"Parasitol Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1016\/j.vaccine.2015.09.096","article-title":"Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines","volume":"33","author":"Richie","year":"2015","journal-title":"Vaccine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13567-015-0177-0","article-title":"Vaccination of pigs with the S48 strain of Toxoplasma gondii \u2013 safer meat for human consumption","volume":"46","author":"Burrells","year":"2015","journal-title":"Vet Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1128\/IAI.02756-14","article-title":"Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infection","volume":"83","author":"Fox","year":"2015","journal-title":"Infect Immun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00465\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T03:32:33Z","timestamp":1660620753000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00465\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2018.00465"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00465","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"article-number":"465"}}